Sumitomo Mitsui Trust Holdings, Inc. Veracyte, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,263,939 shares of VCYT stock, worth $71.7 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,263,939
Previous 2,493,377
9.2%
Holding current value
$71.7 Million
Previous $98.7 Million
32.02%
% of portfolio
0.05%
Previous 0.07%
Shares
25 transactions
Others Institutions Holding VCYT
# of Institutions
339Shares Held
76.5MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$260 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$247 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$209 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$133 Million1.46% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.08MShares$97.5 Million1.83% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.27B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...